Medical costs of brucellosis patients in Datong of Shanxi province, 2017-2019
10.3760/cma.j.cn112338-20220104-00002
- VernacularTitle:山西省大同市2017-2019年布鲁氏菌病患者医疗费用分析
- Author:
Cuihong ZHANG
1
;
Shenghong LIN
;
Xinrong LIU
;
Shuwei AN
;
Ye GAO
;
Shuo HUANG
;
Yuan DENG
;
Liping WANG
;
Yaming ZHENG
Author Information
1. 中国疾病预防控制中心传染病管理处/传染病监测预警重点实验室，北京 102206
- Keywords:
Brucellosis;
Healthcare utilization;
Medical costs;
Complications
- From:
Chinese Journal of Epidemiology
2022;43(12):1965-1971
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the medical costs and influencing factors of patients diagnosed with Brucellosis in Datong of Shanxi province.Methods:Information on demographics, medical visits, and costs of patients diagnosed with Brucellosis between January 1, 2017, and December 31, 2019, were collected. Health care utilization and medical costs were analyzed from different genders, age groups, underlying diseases, clinical stages, and comorbidities.Results:A total of 2 289 patients (1 715 outpatient and 574 inpatient cases) were included in the analysis. 72.0% (1 649/2 289) were male, with an average age of (49.6±15.5) years; age between 45-59 years was the dominant group (36.2%,829/2 289). The mean age of inpatients (51.4±16.0) was higher than that of outpatients (49.0±15.2)( Z=-4.01, P<0.001). The average number of outpatient visits per outpatient was (1.6±1.5) times. The duration of hospitalization was (14.6±9.9) and (20.8±11.4) days for patients with central nervous system complications and (16.6±9.5) days for vascular system complications. Of the inpatients, 51.0% (293/574) had underlying diseases, and 30.3% (174/574) had endocrine and metabolic diseases. 54.0% (310/574) of inpatients were diagnosed with acute Brucellosis, and 46.0% (264/574) were diagnosed with chronic Brucellosis. A total of 64.3% (369/574) of inpatients had complications, 30.3% (174/574) of digestive system complications, followed by skeletal system complications (29.1%, 167/574). Among outpatients, age significantly affected medical costs ( P<0.001). For inpatients, age and complications and treatment effect were influential factors ( P<0.05). Patients with the combined skeletal system and central nervous system complications had significantly higher medical costs ( P<0.001). Conclusions:The medical costs for outpatient cases of Brucellosis were moderate. However, the economic burden was higher for inpatients, especially those with skeletal and neurological complications. Early detection, diagnosis, and treatment of cases were essential to avoid chronic Brucellosis and its complications and reduce medical costs.
